China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024 Read more
Agilent inaugurates India Solution Center to accelerate innovation and expand the frontiers of science Read more
Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer treatment Read more
Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy challenges Read more